Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
LGND
— Ligand Pharmaceuticals Incorporated
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 9, 2026
REVENUE
$51.7M
-13.3%
NET MARGIN
-25.8%
-100.9 PTS
EPS
-$0.67
-129.5%
FREE CASH FLOW
$48.5M
+5.7%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →